16 September 2014 - Deborah Wilkes
Archived
The European Union's Pharmacovigilance Risk Assessment Committee (PRAC) will discuss ambroxol and bromhexine at its meeting in December 2014, after requesting further information on the expectorants.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.